Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.34B | 2.23B | 1.84B | 1.97B | 1.97B |
Gross Profit | 663.23M | 1.48B | 1.10B | 1.51B | 1.01B |
EBITDA | -861.91M | -253.39M | -1.46B | -437.63M | -60.13M |
Net Income | -1.73B | -758.25M | -1.83B | -745.43M | -1.16B |
Balance Sheet | |||||
Total Assets | 6.96B | 7.87B | 7.97B | 9.44B | 5.85B |
Cash, Cash Equivalents and Short-Term Investments | 1.72B | 2.24B | 2.66B | 4.46B | 2.05B |
Total Debt | 2.50B | 3.10B | 1.97B | 1.15B | 2.46B |
Total Liabilities | 5.15B | 5.07B | 5.73B | 5.22B | 4.60B |
Stockholders Equity | 1.73B | 2.70B | 2.15B | 4.06B | 1.05B |
Cash Flow | |||||
Free Cash Flow | -456.90M | -895.64M | -767.70M | -721.58M | -62.04M |
Operating Cash Flow | -332.22M | -595.70M | -729.89M | -675.19M | -47.91M |
Investing Cash Flow | 48.03M | -288.58M | -1.48B | -1.23B | -106.78M |
Financing Cash Flow | -171.99M | 821.71M | 66.75M | 3.94B | 1.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | €10.28B | 15.64 | 6.90% | 2.30% | -17.90% | 136.68% | |
65 Neutral | HK$2.46B | 66.73 | 3.79% | ― | 17.66% | 97.73% | |
57 Neutral | HK$14.21B | 10.19 | -0.60% | 4.64% | 7.08% | -40.08% | |
55 Neutral | $4.99B | ― | -16.87% | ― | -2.35% | -837.50% | |
52 Neutral | HK$7.92B | ― | -77.88% | ― | -41.17% | -103.00% | |
49 Neutral | HK$6.80B | ― | -3.94% | 2.74% | -14.05% | 68.56% | |
46 Neutral | HK$2.62B | ― | -36.81% | ― | -14.38% | -56.66% |
Weimob Inc. has announced a board meeting scheduled for August 20, 2025, to review and approve the company’s interim results for the first half of the year ending June 30, 2025. The meeting will also consider the potential declaration of an interim dividend, which could impact shareholder returns and reflect the company’s financial health and strategic direction.
The most recent analyst rating on (HK:2013) stock is a Sell with a HK$1.55 price target. To see the full list of analyst forecasts on Weimob stock, see the HK:2013 Stock Forecast page.
Weimob Inc. announced the grant of 3,861,000 restricted share units (RSUs) to 173 employees under its 2020 RSU Scheme. This initiative aims to reward past contributions and incentivize future performance, aligning with the company’s strategic goals for long-term growth. The RSUs will vest over four years, contingent on performance targets, and include a clawback mechanism to ensure alignment with company objectives.
The most recent analyst rating on (HK:2013) stock is a Sell with a HK$1.55 price target. To see the full list of analyst forecasts on Weimob stock, see the HK:2013 Stock Forecast page.
Weimob Inc. successfully held its Annual General Meeting on May 16, 2025, where all proposed resolutions were passed by shareholders. Key decisions included the re-election of directors, re-appointment of PricewaterhouseCoopers as auditors, and granting mandates to the board for share issuance and repurchase. These resolutions reflect Weimob’s commitment to maintaining strong governance and strategic flexibility, potentially bolstering its market position and shareholder confidence.
The most recent analyst rating on (HK:2013) stock is a Sell with a HK$1.55 price target. To see the full list of analyst forecasts on Weimob stock, see the HK:2013 Stock Forecast page.